IL-15/IL-15Rα-targeted CRISPRa boosts NK cell effector function against HIV-infected cells

Clicks: 11
ID: 338943
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #107 of 108 articles by views in journal of leukocyte biology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Like many other immune cell types, natural killer (NK) cells exhibit impaired functionality in people with HIV (PWH), limiting their ability to efficiently target and eliminate HIV-infected cells and contributing to the persistence of the HIV reservoir. Recently, adoptive NK cell therapy using activated or engineered NK cells has emerged as a promising immunotherapeutic strategy for cancer; however, its application to HIV remains in the early stages of development. NK cells primarily rely on interleukin-15 (IL-15) signaling for their development, survival, and maintenance, and dysregulated IL-15 signaling has been reported in PWH. We hypothesized that simultaneous enhancement of IL-15 and IL-15 receptor alpha (IL-15Rα) expression would improve NK cell effector function and promote clearance of HIV reservoir. Utilizing dCas9-VPR-mediated multiplex CRISPR activation (CRISPRa), we successfully upregulated both IL-15 and IL-15Rα expression in the same primary NK cells without altering the genomic sequence. CRISPRa-treated NK cells displayed increased IL-15 and IL-15Rα transcript levels, as measured by RT-qPCR and significantly elevated surface expression of IL-15Rα, as determined by flow cytometry. Enhanced IL-15/IL-15Rα expression increased NK cell metabolic activity and cytotoxicity against target K562 cells, a chronic myelogenous leukemia cell line, indicating improved effector function. Furthermore, in co-culture experiments using an HIV-positive T-cell line, IL-15/IL-15Rα-CRISPRa-treated NK cells demonstrated enhanced target cell elimination and increased secretion of IFN-γ. Together, these findings provide a proof of concept that multiplex CRISPRa can be used to enhance NK cell function, representing a novel strategy to improve persistence and therapeutic efficacy in HIV and other disease settings.
Reference Key
openalex_W7225310055 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors S. Brancazio, Tricia H. Burdo, Liang Shan, Rafal Kaminski
Are you one of these authors? Claim your profile
Journal journal of leukocyte biology
Year 2026
DOI
10.1093/jleuko/qiag140
URL
https://doi.org/10.1093/jleuko/qiag140
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.